Quantcha now offering unlimited commission-free options trading.
Quantchabot has detected a promising Short Risk Reversal trade opportunity for INTRA-CELLULAR THERAPIES INC. (ITCI) for the 18-Sep-2020 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine.
ITCI was recently trading at $18.43 and has an implied volatility of 227.83% for this period. Based on an analysis of the options available for ITCI expiring on 18-Sep-2020, there is a 34.13% likelihood that the underlying will close within the analyzed range of $12.75-$18.43 at expiration. In this scenario, the average linear return for the trade would be 49.83%.
Trending on StockTwits: StockTwits® is a financial communications platform for the financial and investing community. On their site, INTRA-CELLULAR THERAPIES INC. was recently trending, indicating that breaking news and/or market activity has significantly impacted sentiment toward the stock. This movement can be interpretted as a sign of more near-term price movement for the underlying.
Trade approach: The recent sentiment change in ITCI on StockTwits appears to be moderately negative, indicating that the stock is likely to follow in that direction for investors trading on sentiment. As a result, a bearish strategy could prove effective if the sentiment ultimately turns out to drive trading.
Upside potential: Using this bearish strategy, the trade would be profitable if INTRA-CELLULAR THERAPIES INC. closed at or below $20.77 on 18-Sep-2020. Based on our analysis, there is a 62.72% likelihood of this return.
Downside risk: As with any options trade, there is a substantial downside risk where you may lose most or all of your investment.
To analyze this trade in depth, please visit the Quantcha Options Search Engine.